Security key
92532F100
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 233,778,905
- Total 13F value
- $97,614,728,920
- Share change
- -847,545
- Put/Call ratio
- 111%
- SEC-reported price per share
- $418.01
- Number of holders
- 1,481
- Value change
- -$351,588,308
- Number of buys
- 760
- Number of sells
- 612
- Shares outstanding
- 254,406,089
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
1,481
Top holders
10
VRTX full security history
Ownership snapshot
Full 13F holder table
VERTEX PHARMACEUTICALS INC / MA SEC filings
VERTEX PHARMACEUTICALS INC / MA company facts
Broader feeds
Ownership snapshot
Top reported holders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 8.8%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 8.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
8.8%
BlackRock Finance, Inc.
8.6%
Capital World Investors
8.6%
FMR LLC
5.1%
STATE STREET CORP
4.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
8.8%
|
$9,066,396,221
22,282,180 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
8.6%
|
$8,903,242,772
21,881,203 shares
|
— | 31 Dec 2023 |
| Capital World Investors |
13F
Company
|
8.6%
|
$8,872,586,480
21,805,770 shares
|
— | 31 Dec 2023 |
| FMR LLC |
13F
Company
|
5.1%
|
$5,281,233,200
12,979,511 shares
|
— | 31 Dec 2023 |
| STATE STREET CORP |
13F
Company
|
4.7%
|
$4,916,784,706
12,083,818 shares
|
— | 31 Dec 2023 |
| ALLIANCEBERNSTEIN L.P. |
13F
Company
|
2.8%
|
$2,864,398,995
7,039,738 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1,481
Shares
233,778,905
Rows available
1,481
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
1,481
Q1 2024 holders
1,481
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|